Literature DB >> 16693922

THE PNEUMOCOCCIDAL POWER OF WHOLE BLOOD: I. Description of Method. Results in Individuals with No History of Lobar Pneumonia.

W D Sutliff1, D R Rhoades.   

Abstract

Year:  1930        PMID: 16693922      PMCID: PMC435681          DOI: 10.1172/JCI100293

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA I. NATURAL IMMUNE SUBSTANCES.

Authors:  O H Robertson; J B Graeser; L T Coggeshall; M A Harrison
Journal:  J Clin Invest       Date:  1934-07       Impact factor: 14.808

2.  THE PNEUMOCOCCIDAL POWER OF WHOLE BLOOD: II. Estimations in Lobar Pneumonia.

Authors:  W D Sutliff; D R Rhoades
Journal:  J Clin Invest       Date:  1930-08       Impact factor: 14.808

3.  PROTECTIVE ACTIVITY OF NORMAL HUMAN AND ANIMAL SERA FOR SULFAPYRIDINE-TREATED MICE INFECTED WITH PNEUMOCOCCI.

Authors:  S Spicer
Journal:  J Clin Invest       Date:  1942-07       Impact factor: 14.808

4.  Viable Pneumococci and Pneumococcic Specific Soluble Substance in the Lungs from Cases of Lobar Pneumonia.

Authors:  R N Nye; A H Harris
Journal:  Am J Pathol       Date:  1937-09       Impact factor: 4.307

5.  ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

Authors:  W D Sutliff; M Finland
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.